Ramesh et al. demonstrated for the first time that IL-24-mediates anti-angiogenic activity in lung tumor xenograft by reducing the number of CD31 positive endothelial cells, a marker indicative of reduced blood vessels in the tumor [29]. This evidence concerns the gene IL24 and neoplasm.